Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized thiopurine therapy in ulcerative colitis
NL-OMON47463Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in autoimmune colitis comparing Mercaptopurine arm with Placebo arm (2 arms). Primary endpoint: Clinical and endoscopic remission at week 52. Started Nov 2016; status: active, not recruiting.
02
Drugs
mercaptopurine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON47463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47463.